APA-viite

Goldsmith, S. R., Saif Ur Rehman, S., Shirai, C. L., Vij, K., & DiPersio, J. F. (2019). Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib. Blood Adv.

Chicago-tyylinen lähdeviittaus

Goldsmith, Scott R., Sana Saif Ur Rehman, Cara L. Shirai, Kiran Vij, ja John F. DiPersio. "Resolution of Secondary Hemophagocytic Lymphohistiocytosis After Treatment With the JAK1/2 Inhibitor Ruxolitinib." Blood Adv 2019.

MLA-viite

Goldsmith, Scott R., et al. "Resolution of Secondary Hemophagocytic Lymphohistiocytosis After Treatment With the JAK1/2 Inhibitor Ruxolitinib." Blood Adv 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.